Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia

OBJECTIVES: To evaluate the efficacy and safety of nafamostat combined with favipiravir for the treatment of COVID-19. METHODS: We conducted a multicenter, randomized, single-blind, placebo-controlled, parallel assignment study in hospitalized patients with mild-to-moderate COVID-19 pneumonia. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Mahoko, Okugawa, Shu, Kashiwabara, Kosuke, Moritoyo, Takashi, Kanno, Yoshiaki, Jubishi, Daisuke, Hashimoto, Hideki, Okamoto, Koh, Tsushima, Kenji, Uchida, Yasuki, Mitsumura, Takahiro, Igari, Hidetoshi, Tsutsumi, Takeya, Araoka, Hideki, Yatera, Kazuhiro, Yamamoto, Yoshihiro, Nakamura, Yuki, Otani, Amato, Yamashita, Marie, Wakimoto, Yuji, Shinohara, Takayuki, Adachi-Katayama, Maho, Oyabu, Tatsunori, Kanematsu, Aoi, Harada, Sohei, Takeshita, Yuichiro, Nakano, Yasutaka, Miyazaki, Yasunari, Sakao, Seiichiro, Saito, Makoto, Ogura, Sho, Yamasaki, Kei, Kawasuji, Hitoshi, Hataji, Osamu, Inoue, Jun-Ichiro, Seto, Yasuyuki, Moriya, Kyoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810545/
https://www.ncbi.nlm.nih.gov/pubmed/36610659
http://dx.doi.org/10.1016/j.ijid.2022.12.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810545/
https://www.ncbi.nlm.nih.gov/pubmed/36610659
http://dx.doi.org/10.1016/j.ijid.2022.12.039

Ejemplares similares